1. Home
  2. VKTX vs RNST Comparison

VKTX vs RNST Comparison

Compare VKTX & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • RNST
  • Stock Information
  • Founded
  • VKTX 2012
  • RNST 1904
  • Country
  • VKTX United States
  • RNST United States
  • Employees
  • VKTX N/A
  • RNST N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • RNST Major Banks
  • Sector
  • VKTX Health Care
  • RNST Finance
  • Exchange
  • VKTX Nasdaq
  • RNST Nasdaq
  • Market Cap
  • VKTX 3.5B
  • RNST 3.3B
  • IPO Year
  • VKTX 2015
  • RNST N/A
  • Fundamental
  • Price
  • VKTX $34.42
  • RNST $36.76
  • Analyst Decision
  • VKTX Strong Buy
  • RNST Buy
  • Analyst Count
  • VKTX 13
  • RNST 6
  • Target Price
  • VKTX $86.92
  • RNST $42.20
  • AVG Volume (30 Days)
  • VKTX 4.1M
  • RNST 588.9K
  • Earning Date
  • VKTX 07-23-2025
  • RNST 07-22-2025
  • Dividend Yield
  • VKTX N/A
  • RNST 2.39%
  • EPS Growth
  • VKTX N/A
  • RNST N/A
  • EPS
  • VKTX N/A
  • RNST 2.24
  • Revenue
  • VKTX N/A
  • RNST $735,631,000.00
  • Revenue This Year
  • VKTX N/A
  • RNST $40.84
  • Revenue Next Year
  • VKTX N/A
  • RNST $13.45
  • P/E Ratio
  • VKTX N/A
  • RNST $16.43
  • Revenue Growth
  • VKTX N/A
  • RNST 17.24
  • 52 Week Low
  • VKTX $18.92
  • RNST $26.97
  • 52 Week High
  • VKTX $81.73
  • RNST $39.63
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 73.08
  • RNST 47.10
  • Support Level
  • VKTX $31.22
  • RNST $37.27
  • Resistance Level
  • VKTX $33.61
  • RNST $39.41
  • Average True Range (ATR)
  • VKTX 1.77
  • RNST 0.84
  • MACD
  • VKTX 0.32
  • RNST -0.31
  • Stochastic Oscillator
  • VKTX 89.49
  • RNST 26.80

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: